OXIGENE, INC.

Company

Oncotelic Therapeutics, Inc.

Filed

May 2, 2008

Accession Number

0000950135-08-003302

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →